(Jacob Bruns, Headline USA) Republicans in the U.S. Senate and House are launching investigations into Big Pharma giant Pfizer after the release of a Project Veritas video that exposed Pfizer’s alleged manipulations of COVID variants, Becker News reported.
After receiving record government contracts to create gene-altering mRNA vaccines, it now appears that Pfizer CEO Albert Bourla and his mega-corporation have been plotting COVID variant manipulations to continue to line their pockets.
Sen. Marco Rubio, R-Fla., penned a letter to Bourla, noting that the CEO and his company engaged in nefarious practices by taking advantage of public faith in “the Science.”
“An investigative report suggests that Pfizer may be conducting gain-of-function research, which it dubs ‘directed evolution’ research to mutate the SARS-CoV-2 virus to create additional, more potent variants and vaccines to combat future variants,” Rubio wrote. “This type of research, similar to gain-of-function research, has long been controversial, and is suspected to be the cause of the COVID-19 pandemic.”
He also noted that Bourla and his company lied about the side-effects of the jab while securing state-guaranteed immunity to lawsuits.
“Pfizer has put its desire for profit over the concern of national and global health and must hold itself accountable,” Rubio continued.
In the House, Rep. Marjorie Taylor Greene also demanded an investigation.
“The Pfizer Director…is caught on video discussing mutating the virus to change the vaccines & how Covid is a cash cow!” Greene tweeted. “Pfizer took BILLIONS of federal [dollars]. Our Covid Select Subcommittee MUST investigate!”
Greene was of course alluding to the aforementioned Project Veritas bombshell video released earlier this week which exposed Pfizer’s designs on Americans.
“One of the things we’re exploring is like, why don’t we just mutate it [COVID] ourselves so we could create — preemptively develop new vaccines, right? So, we have to do that,” Jordon Trishton Walker, Pfizer director of research and development with strategic operations and mRNA scientific planning told an undercover reporter from Project Veritas.
“If we’re gonna do that though, there’s a risk of like, as you could imagine — no one wants to be having a pharma company mutating f**king viruses.”
